Greater goods?: Direct-to-consumer testing companies are making a broader case for societal benefits, but not everyone is sold.

Cancer cytopathology

PubMedID: 26972119

Nelson B. Greater goods?: Direct-to-consumer testing companies are making a broader case for societal benefits, but not everyone is sold. Cancer Cytopathol. 2016;124(3):159-60.
An abstract is not available. Please access the article through the links below.